Korg just officially unveiled the Phase8 synthesizer, after years of tinkering by a team led by legendary engineer Tatsuya Takahashi. This is a highly experimental synthesizer, but it's not a concept ...
On April 3, the GRAMMY-winning Kronos Quartet will release Glorious Mahalia via Smithsonian Folkways, a new album honoring the life, voice, and activism of New Orleans–born gospel legend Mahalia ...
NL Industries remains a strong long-term income play, despite recent share price decline and rangebound technicals. NL's real trailing dividend yield is an impressive 10.4%, boosted by special ...
Ignota Labs has harvested more assets for its drug candidate rehabilitation scheme, snapping up Kronos Bio’s clinical pipeline months after a series of setbacks drove the biotech off public markets. U ...
NANO Nuclear Energy Inc. (NASDAQ: NNE) announced its third fiscal quarter results, revealing significant milestones in the development of its KRONOS Micro Modular Reactor (MMR). The company advanced U ...
The original PS1 inspired countless careers, as for many the game Music by Jester Interactive gave them their first taste of music production. We’ve seen various other digital audio workstations ...
Investing.com -- S&P Global Ratings downgraded Concord, Ontario-based Kronos Acquisition Holdings Inc. to ’CCC+’ from ’B-’ due to tightening liquidity and ongoing operational challenges. The downgrade ...
WICHITA, Kan. (KSNW) – Top distance runners from across the Midwest are making their way to Wichita this weekend for a brand-new track event aiming to raise the bar: the first-ever Kronos Race Night ...
Bitget Partners with Kronos Research to Deliver Institutional-Grade Liquidity and Trading Efficiency
“The collaboration is yet another step in Bitget’s efforts towards delivering world-class institutional-grade trading services. With Kronos Research, Bitget strengthens its platform’s efficiency, ...
CAMBRIDGE, Mass. - Kronos Bio, Inc. (NASDAQ:KRON), a biopharmaceutical firm specializing in small molecule therapeutics for cancer and other diseases, announced today it has reached a definitive ...
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The biotech downturn claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results